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TMEM16A Calcium-Activated Chloride Channel
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The binding of calcium-calmodulin (CaCaM) to various cation channels has
been found to modulate the channel function. Recently, the anion perme-
ability of the TMEM16A calcium-activated chloride channel was also
reported to be altered upon modulation by CaCaM (Jung et al., Proc Natl
Aca Sci: 110: 360-365, 2013). This modulation effect could be physiologi-
cally important for many cellular functions that involve the TMEM16A chan-
nel. To study the modulation of TMEM16A by CaCaM, we expressed the
TMEM16A channel in HEK 293 cells and performed excised inside-out patch
recordings. The anion permeability ratios were evaluated based on the
reversal potentials in bi-ionic conditions in which various anions were placed
in the intracellular side with an equal concentration of chloride ions in the
extracellular solution. We used both the voltage-clamp and the current-
clamp (I=0) recording approaches, and surprisingly found that CaCaM,
when applied to the intracellular side of the channel, did not alter reversal po-
tentials. The activity of CaCaM was verified by a positive control experiment
in which the current of the olfactory cyclic nucleotide-gated channel encoded
by CNGA2 was inhibited upon the application of intracellular CaCaM. These
results contradict the recent finding that intracellular CaCaM alters the anion
permeability of the TMEM16A channel. Our experiments also show that the
measurement of reversal potentials is imprecise if the recorded current is &gt;
1-2 nA at þ40 mV, likely due to a series-resistance problem. We notice that
the reversal potential change in Jung et al is particularly prominent at high
intracellular [Ca2þ], which activates huge calcium-activated currents
(&gt;5-10 nA) in whole-cell configurations. Whether this technical issue
causes the change of the reversal potential in Jung et al. requires further
scrutiny.
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Ca2þ-activated Cl- channels (CaCCs) recorded from vascular smooth muscle
cells (VSMCs) are regulated by phosphorylation involving CaMKII, Calci-
neurin and PP1 (Ayon et al., J Biol Chem 2009;284:32507-32521).
TMEM16A, a recently identified anion channel gene, is believed to encode
for CaCCs in VSMCs (Davis et al. Am J Physiol Cell Physiol
2010;299:C948-C959; Manoury et al. J Physiol 2010;588:2305-2314) and
to contribute to vascular tone (Davis et al. Br J Pharmacol
2013;168:773-784). This study aimed to determine whether Ca2þ-activated
Cl- currents (IClCa) generated by transient expression of mouse TMEM16A
in HEK-293 cells are regulated by kinase and phosphatase activity. Immuno-
cytochemical experiments confirmed the presence of PP1a, PP1b/d, PP1g,
PP2A and CaMKII in HEK-293 cells, and mRNA transcripts for all four
known mammalian CaMKII isoforms (CaMKIIa, b, g and d) were identified
by RT-PCR in these cells. Similar to VSMCs, TMEM16A-induced IClCa dis-
played significant rundown in cells dialyzed with 5mM ATP; this effect was
potently inhibited by removing ATP. The attenuation of TMEM16A-IClCa
rundown in the absence of ATP was suppressed by intracellular application
of the PP1/PP2A inhibitor okadaic acid (30 nM). Intracellular application
of KN-93 (10 mM) or autocamtide-2-related inhibitory peptide (ARIP; 5
mM), two specific CaMKII inhibitors led to a significant attenuation of
TMEM16A-IClCa rundown in the presence of ATP. While mutating a threo-
nine 623 of TMEM16A, a putative CaMKII phosphorylation site, to an
alanine did not affect rundown, a serine to alanine mutation at position 550
attenuated ICl(Ca) rundown to an extent similar to that produced by KN-93.
These data suggest that TMEM16A-IClCa is regulated by CaMKII and PP1
in a manner similar to CaCCs in VSMCs. Our data also suggest that serine
550 is an important contributor to the regulation of IClCaby CaMKII.734-Pos Board B489
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Ca2þ-activated Cl- channels (CaCCs) in vascular and many non-vascular
smooth muscle cells are thought to be encoded by the gene TMEM16A.
Our group recently showed that the amplitude and pharmacology of CaCCs
currents (IClca) are influenced by cholesterol depletion (Sones et al. Cardi-
ovasc Res 2010;87:476-484). The aim of this study was to investigate the
mechanism by which native CaCCs are regulated by cholesterol depletion
and the possible role of phosphatidylinositol 4, 5-bisphosphate (PIP2).
Freshly isolated pulmonary artery myocytes were obtained from male Wis-
tar rats (200-225g), sacrificed in accordance with Schedule 1 of the United
Kingdom Animals Act (1986). In whole cell patch clamp recording mode,
macroscopic IClca were elicited by dialysing the cells with a pipette solution
set to 500nM ‘free’ [Ca2þ]. Single channel inside-out recordings were also
induced by 500nM [Ca2þ] and displayed similar characteristics to earlier
characterisation. These currents displayed the distinct voltage- and time-
dependent properties described in previous studies. Cholesterol depletion
from the cell membrane through the application of 3mg.ml1 methyl-b-
cyclodextrin (mbcd) augmented IClca, which was prevented by application
of the TMEM16A specific inhibitor T16Ainh-A01. Augmentation by mbcd
was also sensitive to the phospholipase C inhibitor U73312, but not the
inactive analogue U73343. Inhibiting PIP2 synthesis by incubation with
20mM wortmannin, a PI-4 kinase inhibitor augmented IClca and prevented
the stimulatory effects of mbcd. Enrichment of the pipette solution
with 1mM diC-8 PIP2 attenuated IClcaand suppressed the effect of mbcd.
Wortmannin and PIP2 effects on IClca were replicated in single channel
inside-out recordings. Furthermore, the application of the poly-cation
Poly-L-lysine (50mg/ml), which scavenges PIP2, augmented IClca. This
study suggests that cholesterol depletion of the cell membrane increases
TMEM16A/CaCC activity, partly through the removal of the inhibitory
effect of PIP2.
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TMEM16A(a)/Anoctamin-1 (Ano1) is a calcium-activated chloride chan-
nel. Using blue native polyacrylamide gel electrophoresis (BN-PAGE)
and chemical cross-linking, we have demonstrated that the recombinantly
expressed mouse Ano1 (mAno1) assembles as an obligate homodimer in
both Xenopus laevis oocytes and HEK293 cells (Fallah et al Molecular
& Cellular Proteomics 10: 10.1074/mcp.M110.004697, 1-10, 2011). Here
we replaced individual residues by cysteines in the four putative mAno1
ectodomains, whose boundaries were based on the predictions of the
MEMSAT3 topology program (Jones, Bioinformatics 23, 538-544. 2007).
As a quantifiable readout we examined the accessibility of the introduced
cysteine residue at the extracellular membrane surface of intact X. laevis
oocytes for a thiol-reactive fluorescent maleimide dye. The mAno1 mu-
tants were purified by Ni-NTA affinity chromatography, resolved by
BN-PAGE and SDS-PAGE, and visualized by scanning of the metaboli-
cally incorporated [35S]methionine and the thiol-bound dye fluorescence.
All the mutants examined appeared in the oocyte plasma membrane in
the homodimeric state. Based on a total of 42 mAno1 cysteine mutants
analyzed so far, the experimentally determined boundaries of the four
mAno1 ectodomains (EC1-EC4) in terms of the residues positions are:
358-406 (EC1; predicted 359-402), 511-531 (EC2, predicted 513-527),
598-630 (EC3, predicted 598-707) and 791-848 (EC4, predicted
790-748). The major deviation pertains to EC3, which according to
cysteine accessibility is much shorter, comprising residues 598-629 instead
of residues 598-707 predicted by the MEMSAT3 program. Our data sug-
gest that TM6 is represented by residues 630-650 (and not residues 708-
732 predicted by MEMSAT3). In contrast, the predicted position of
TM7 (residues 765-789) is in line with our experimental data. Our data
confirm and extent earlier findings of Yu, Duran, Qu, Cui and Hartzell
(Circ. Res. 110: 990-999, 2012).
